-
Mashup Score: 4Can a Novel Stent Design Improve Long-Term Outcomes of Percutaneous Coronary Intervention? - 17 day(s) ago
Compared with bare metal stents (and balloon angioplasty), drug-eluting stents (DES) have markedly improved the outcomes of percutaneous coronary
Source: www.jwatch.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 3
AbstractAims. While complications of transcatheter aortic valve replacement (TAVR) have decreased, they still occur commonly and may negatively impact both
Source: academic.oup.comCategories: General Medicine News, CardiologistsTweet-
@drandrewsharp @GilbertTangMD @arnoldgehrke and I previously published data from the TVT registry showing that the adjusted HR for mortality with >=moderate PVL was 1.4, and this was after adjusting for all other complications. A relative risk of 2 seems very high. https://t.co/t0SJ1DWG1x
-
-
Mashup Score: 10
Home > Call For Science > Topics, Categories, Guidelines CONNECT with global pioneers. DRIVE scientific advancements worldwide. SHAPE the future of cardiology. Get the latest news and information from CRF. © 2024, Cardiovascular Research Foundation ®. All rights reserved. This website uses cookies to ensure you get the best experience on our website. Read
Categories: General Medicine News, CardiologistsTweet-
RT @TCT_ME_: The call for science is now open…submit your work Abstracts Challenging cases LBCT 🔗 https://t.co/vexerxkk0W @mirvatalasna…
-
-
Mashup Score: 2Mediators of Improvement in TAVR Outcomes Over Time: Insights From the STS-ACC TVT Registry - 2 month(s) ago
BACKGROUND: Over the past decade, there has been substantial improvement in outcomes after transcatheter aortic valve replacement. Many patient and procedural factors have also changed over that time
Source: www.ahajournals.orgCategories: General Medicine News, CardiologistsTweet-
@dr_benoy_n_shah @kaulcsmc Exactly. And in addition to device iteration, there has been technical iteration (CT imaging, perc access vs cutdown, conscious sedation vs general anesthesia)— all of which have contributed to improving short and longer term outcomes. https://t.co/7rPGN0g7b1 @arnoldgehrke
-
-
Mashup Score: 3Comparative Effectiveness of ICD Versus Non-ICD Therapy in Contemporary Heart Failure Patients With a Low Risk for Arrhythmic Death (CONTEMP-ICD) - 2 month(s) ago
The project title and summary on this page were provided by and reflect the opinions and work of the awardee and do not necessarily represent the views of PCORI. The implantable cardioverter defibrillator (ICD) is placed inside the heart of patients with risk of sudden death and can terminate a life-threatening heart rhythm disturbance by delivery of therapy or shock to the patient. Currently, there is a recommendation to place an ICD for the prevention of sudden cardiac death inside the heart chambers
Source: www.pcori.orgCategories: General Medicine News, CardiologistsTweet-
@DrDave01 @drjohnm Trial (CONTEMP ICD) has been funded by PCORI... https://t.co/m6jk1FlPVT
-
-
Mashup Score: 3Percutaneous Microaxial Left Ventricular Assist Device for Patients With Cardiogenic Shock - 4 month(s) ago
This comparative effectiveness research study compares percutaneous microaxial left ventricular assist device vs alternative treatments among patients presenting with acute myocardial infarction with cardiogenic shock.
Source: jamanetwork.comCategories: General Medicine News, CardiologistsTweet-
@Babar_Basir @MichaelMegalyMD @BartoszHudzik @ESC_Journals @DrKevinBuda @mirvatalasnag @CMichaelGibson @DFCapodanno @AnkurKalraMD @vlgmrc @Drroxmehran @KardiologieHH @HawranekMichal @DocSavageTJU @CVPrevInterv @rwyeh Exactly. You can actually study the question using observational methods, but as @ZaidAlMarzooq and @rwyeh showed last year, it's pretty much impossible to do the study well because of intractable confounding. https://t.co/BORSuuRcfD
-
-
Mashup Score: 15A Comparison of Balloon-Expandable-Stent Implantation with Balloon Angioplasty in Patients with Coronary Artery Disease | NEJM - 4 month(s) ago
Balloon-expandable coronary-artery stents were developed to prevent coronary restenosis after coronary angioplasty. These devices hold coronary vessels open at sites that have been dilated. However…
Source: www.nejm.orgCategories: General Medicine News, CardiologistsTweet-
@DocSavageTJU @NEJM @fischman_david @JWMoses @GreggWStone @Drroxmehran @mirvatalasnag @mmamas1973 @DLBHATTMD @SVRaoMD @jgranadacrf @BavariaMd @TCTMD @TJUHospital @SandeepNathanMD @DrMarthaGulati @SABOURETCardio @hmkyale @aayshacader @BinitaShahMD @MarcoJe80135689 @KardiologieHH @angioplastyorg Seminal publication (along with the first Benestent trial), which helped propel interventional cardiology into the field it is today. Here's the Benestent reference for those who are interested. https://t.co/OAL2zMqtsD
-
-
Mashup Score: 2ClinicalTrials.gov - 5 month(s) ago
Hide glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information.
Source: clinicaltrials.govCategories: General Medicine News, CardiologistsTweet-
@adnanalkhouli Sorry for the broken link. Use this one... https://t.co/F5thTQeEcU
-
-
Mashup Score: 11ClinicalTrials.gov - 5 month(s) ago
Hide glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information.
Source: clinicaltrials.govCategories: General Medicine News, CardiologistsTweet-
@adnanalkhouli We are in the home stretch of a nationally representative, racially and ethnically diverse study of the prevalence of valvular heart diseased in the US (https://t.co/o2JlFzoY7i). Results should be available in 2025.
-
-
Mashup Score: 2A cost-effectiveness analysis of exercise as a health promotion activity. | AJPH | Vol. 78 Issue 11 - 6 month(s) ago
We used cost-effectiveness analysis to estimate the health and economic implications of exercise in preventing coronary heart disease (CHD). We assumed that nonexercisers have a relative risk of 2.0 for a CHD event. Two hypothetical cohorts (one with exercise and the other without exercise) of 1,000 35-year-old men were followed for 30 years to observe differences in the number of CHD events, life expectancy, and quality-adjusted life expectancy. We used jogging as an example to calculate cost, injury rates, adherence, and the value of time spent. Both direct and indirect costs associated with exercise, injury, and treating CHD were considered. We estimate that exercising regularly results in 78.1 fewer CHD events and 1,138.3 Quality Adjusted Life Years (QALYs) gained over the 30-year study period. Under our base case assumptions, which include indirect costs such as time spent in exercise, exercise does not produce economic savings. However, the cost per QALY gained of $11,313 is favo
Source: ajph.aphapublications.orgCategories: General Medicine News, CardiologistsTweet-
@drandrewsharp Link for those interested in the details... https://t.co/OS1TJZk3fH
-
RT @JWatch: Can a novel stent design improve long-term outcomes of percutaneous coronary intervention? https://t.co/dtR5OoP37m #CardioTwi…